Alexander Sigalov

Prior to founding SignaBlok, Inc. (Worcester, MA) in 2009, Dr. Sigalov worked at Massachusetts Institute of Technology (Cambridge, MA), and later, as a faculty at the University of Massachusetts Medical School. He is the sole inventor of methods and compositions created through the SCHOOL platform and integrated nanosystems for drug targeted delivery that can be used to prevent or treat multiple diseases with unmet needs. Dr. Sigalov has been advising ZATA since 2016.